Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Study finds lower uptake of HPV vaccination among racial/ethnic minorities

A new Boston University School of Medicine (BUSM) study has found that improving Human papillomavirus (HPV) vaccination rates in black women may require culturally sensitive approaches that address ethnic-specific barriers.

14 Nov 2012

Guided Therapeutics files amended PMA with FDA for LuViva Advanced Cervical Scan

Guided Therapeutics, Inc., today announced that it has submitted its premarket approval (PMA) Amendment for the LuViva Advanced Cervical Scan, a non-invasive device used to detect cervical disease that leads to cancer, instantly and at the point of care.

13 Nov 2012

HPV testing and cervical screening: an interview with Dr Rosa Legood

Human papillomavirus is a virus that is transmitted through sexual contact. In most cases the virus is transient and causes no harm, however in some cases it can go on to cause pre-cancer lesions and cervical cancer.

7 Nov 2012

Cervical cancer risk remains high after CIN treatment

Women who undergo treatment for screening-detected cervical intraepithelial neoplasia are more than four times more likely to develop cervical cancer than women with normal smear tests, research suggests.

5 Nov 2012

Weill Cornell researchers awarded Grand Challenges Explorations grants

Weill Cornell Medical College announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

3 Nov 2012

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside living cells to kill infectious microbes.

3 Nov 2012

HPV test of cure cheaper and more effective than cytology testing for women following pre-cervical cancer treatment

Testing women to see if they are cured of HPV (the virus that can cause genital warts and cervical cancer) following treatment for abnormal cells on the surface of the cervix is more effective and cheaper than cytology testing (cervical screening) alone, suggests a study published on bmj.com.

2 Nov 2012

UC Irvine, Cal State Fullerton partner to help reduce cancer disparities in Orange County

Researchers from UC Irvine's Chao Family Comprehensive Cancer Center and California State University, Fullerton's Health Promotion Research Institute have formed a partnership to help reduce cancer disparities in Orange County.

2 Nov 2012

Link between ChemoFx Drug Response Marker results and RFS of cervical cancer patients

A new study reporting an association between ChemoFx Drug Response Marker results and recurrence free survival (RFS) of cervical cancer patients was presented at the 14th Biennial Meeting of the International Gynecologic Cancer Society (IGCS), held in Vancouver October 13-16, 2012.

2 Nov 2012

Advaxis updates preliminary data from ADXS-HPV Phase 2 trial on cervical cancer

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, updated preliminary data from an ongoing randomized 110 patient Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.

1 Nov 2012

Substantial number of cancer survivors experience poor mental or physical health years after cancer

Survivors of many common cancers enjoy a mental and physical health-related quality of life equal to that of adults who have not had cancer, but survivors of other cancers are in poorer health, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

31 Oct 2012

ACP urges use of performance measures targeting 'low-value services' to reduce overuse, misuse of these approaches

The American College of Physicians released a position paper Monday pressing for "valid, evidence-based measures" as a means of raising physician awareness and changing clinician behavior.

31 Oct 2012

Researchers decode software instructions that drive 3 different forms of acute lymphoblastic leukemia

30 Oct 2012

Scientists decode epigenetic programming of three virulent forms of acute lymphoblastic leukemia

A team of national and international researchers, led by Weill Cornell Medical College scientists, have decoded the key "software" instructions that drive three of the most virulent forms of acute lymphoblastic leukemia (ALL). They discovered ALL's "software" is encoded with epigenetic marks, chemical modifications of DNA and surrounding proteins, allowing the research team to identify new potential biomarkers and therapeutic targets.

29 Oct 2012

Federal appeals court won't hear Planned Parenthood appeal of Texas defunding

Texas Gov. Rick Perry said the state would move immediately to stop providing any funding for Planned Parenthood and other clinics that provide abortions.

29 Oct 2012

Improving global maternal mortality, women's health and related U.S. foreign policy

In the Center for Strategic & International Studies' "Smart Global Health" blog, Phillip Nieburg, senior associate of the CSIS Global Health Policy Center, discusses a recent report he wrote, titled "Improving Maternal Mortality and Other Aspects of Women's Health: The United States' Global Role," "that addresses key challenges to improving maternal mortality and women's health worldwide and talks about what the related priorities of U.S. foreign policy should be."

29 Oct 2012

Research roundup: Patients' unrealistic expectations for chemo; Neighborhood may affect CPR rates; Rate hike reviews working

"To make informed decisions about whether to receive chemotherapy, patients with advanced lung or colorectal cancer need a realistic understanding of its likely benefits," the authors write. Researchers conducted comprehensive reviews of records.

29 Oct 2012

NewYork-Presbyterian/Columbia participates in Symplicity system trial for hypertension

Patients with hypertension whose blood pressure cannot be brought down to safe levels despite taking three or more medications may have some relief coming their way. An innovative, first-of-its-kind clinical trial for a device representing a dramatic shift in treatment approaches for the toughest-to-treat patients is currently being conducted at NewYork-Presbyterian Hospital.

From Medtronic 26 Oct 2012

Weill Cornell’s ChiP now accepts applications for new master's program in health informatics

Informatics is integral to solving the nation's urgent healthcare issues of rising costs and the delivery of quality care. Training the next generation of professionals to develop, implement and research new informatics technologies is vital. Through the Weill Cornell Graduate School of Medical Sciences, the Center for Healthcare Informatics and Policy (CHiP) is now accepting applications for a new master's program in health informatics to do just that.

24 Oct 2012

Roundup: Va. health chief quits, citing new abortion clinic regulations; Texas will shutter women's health program if Planned Parenthood participates

Virginia Health Commissioner Karen Remley resigned Thursday over new GOP-backed regulations that could shutter most Virginia abortion providers as reproductive rights take center stage in pivotal Senate and presidential races.

20 Oct 2012

Cervical Cancer News and Research

Further Reading

Study finds lower uptake of HPV vaccination among racial/ethnic minorities

Guided Therapeutics files amended PMA with FDA for LuViva Advanced Cervical Scan

HPV testing and cervical screening: an interview with Dr Rosa Legood

Cervical cancer risk remains high after CIN treatment

Weill Cornell researchers awarded Grand Challenges Explorations grants

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

HPV test of cure cheaper and more effective than cytology testing for women following pre-cervical cancer treatment

UC Irvine, Cal State Fullerton partner to help reduce cancer disparities in Orange County

Link between ChemoFx Drug Response Marker results and RFS of cervical cancer patients

Advaxis updates preliminary data from ADXS-HPV Phase 2 trial on cervical cancer

Substantial number of cancer survivors experience poor mental or physical health years after cancer

ACP urges use of performance measures targeting 'low-value services' to reduce overuse, misuse of these approaches

Researchers decode software instructions that drive 3 different forms of acute lymphoblastic leukemia

Scientists decode epigenetic programming of three virulent forms of acute lymphoblastic leukemia

Federal appeals court won't hear Planned Parenthood appeal of Texas defunding

Improving global maternal mortality, women's health and related U.S. foreign policy

Research roundup: Patients' unrealistic expectations for chemo; Neighborhood may affect CPR rates; Rate hike reviews working

NewYork-Presbyterian/Columbia participates in Symplicity system trial for hypertension

Weill Cornell’s ChiP now accepts applications for new master's program in health informatics

Roundup: Va. health chief quits, citing new abortion clinic regulations; Texas will shutter women's health program if Planned Parenthood participates

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News